What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Major depressive disorder
His scientific interests lie mostly in Psychiatry, Internal medicine, Bipolar disorder, Antidepressant and Mood disorders.
His biological study spans a wide range of topics, including Meta-analysis and Clinical psychology.
His Internal medicine research is multidisciplinary, relying on both Major depressive disorder, Endocrinology, Oncology and Genotype.
His work carried out in the field of Bipolar disorder brings together such families of science as Genetics, Schizophrenia, Psychosis, CLOCK and Age of onset.
His Antidepressant study incorporates themes from Pharmacogenetics, Pharmacology and Fluvoxamine.
He works mostly in the field of Mood disorders, limiting it down to topics relating to Single-nucleotide polymorphism and, in certain cases, GSK-3, as a part of the same area of interest.
His most cited work include:
- Mindfulness-based stress reduction for stress management in healthy people: A review and meta-analysis. (1006 citations)
- Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings (686 citations)
- Genome-wide association study identifies 30 loci associated with bipolar disorder (518 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Psychiatry, Internal medicine, Bipolar disorder, Depression and Major depressive disorder.
Many of his studies involve connections with topics such as Clinical psychology and Psychiatry.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology, Single-nucleotide polymorphism, Genotype and Antidepressant.
He usually deals with Antidepressant and limits it to topics linked to Pharmacogenetics and Pharmacology and Bioinformatics.
Alessandro Serretti works mostly in the field of Bipolar disorder, limiting it down to concerns involving Mood disorders and, occasionally, Serotonin transporter.
Alessandro Serretti interconnects Comorbidity and Rating scale in the investigation of issues within Depression.
He most often published in these fields:
- Psychiatry (40.43%)
- Internal medicine (33.56%)
- Bipolar disorder (23.20%)
What were the highlights of his more recent work (between 2016-2021)?
- Major depressive disorder (19.59%)
- Psychiatry (40.43%)
- Depression (19.71%)
In recent papers he was focusing on the following fields of study:
Alessandro Serretti focuses on Major depressive disorder, Psychiatry, Depression, Internal medicine and Bipolar disorder.
The concepts of his Major depressive disorder study are interwoven with issues in Antidepressant, Pharmacogenetics, Genome-wide association study and Clinical psychology.
His Antidepressant research is multidisciplinary, incorporating perspectives in Pharmacology and Heritability.
In general Psychiatry study, his work on Antipsychotic often relates to the realm of Suicidal ideation, thereby connecting several areas of interest.
His work deals with themes such as Neuroticism, Oncology and Endocrinology, which intersect with Internal medicine.
The Bipolar disorder study combines topics in areas such as Genetics, Schizophrenia, Mood disorders and Mood.
Between 2016 and 2021, his most popular works were:
- Genome-wide association study identifies 30 loci associated with bipolar disorder (518 citations)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (328 citations)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (242 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Major depressive disorder
Alessandro Serretti mainly focuses on Major depressive disorder, Genome-wide association study, Depression, Internal medicine and Psychiatry.
His studies in Major depressive disorder integrate themes in fields like Antidepressant, Pharmacogenetics and Panic disorder, Agoraphobia.
He interconnects Bipolar disorder, Bioinformatics and Candidate gene in the investigation of issues within Genome-wide association study.
His study on Depression also encompasses disciplines like
- Rating scale which connect with Logistic regression,
- Clinical psychology, which have a strong connection to Mood disorders,
- Prevalence which intersects with area such as Hamilton Rating Scale for Depression, Cross-sectional study and Retrospective cohort study.
His research in Internal medicine intersects with topics in Biological psychiatry, Oncology and Antipsychotic.
His study in Psychiatry is interdisciplinary in nature, drawing from both Meta-analysis and Bristol-Myers.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
